GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Total Equity

Olipass (XKRX:244460) Total Equity : ₩11,857.4 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Olipass Total Equity?

Olipass's total equity for the quarter that ended in Dec. 2024 was ₩11,857.4 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Olipass Total Equity Historical Data

The historical data trend for Olipass's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olipass Total Equity Chart

Olipass Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,213.69 30,155.75 9,226.12 2,320.32 11,857.42

Olipass Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,320.32 735.29 4,112.06 2,010.63 11,857.42

Olipass Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Olipass's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=26279.773-14422.353
=11,857.4

Olipass's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=26279.773-14422.353
=11,857.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olipass Total Equity Related Terms

Thank you for viewing the detailed overview of Olipass's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Olipass Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Olipass Corp (XKRX:244460) » Definitions » Total Equity
Comparable Companies
XKRX:066830 XKRX:266470 XKRX:299480 XKRX:352770 XKRX:283100 XKRX:341170 XKRX:188260 XKRX:251280 XKRX:179530 XKRX:322970 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
16-4, 16 Beon-gil, Dongbaek Jungang-ro, Ace Dongbaek Tower 20th Floor, Giheung-gu, Yongin, KOR, 17015
Website
https://www.olipass.com
Olipass Corp is a South Korea based biotechnology company engaged in developing its platform OliPass PNA which focuses on introducing cationic lipid moiety onto nucleobase. Its pipeline products include SC Injection, Hyper Cholesterolemia, Chemo/Radio-sensitizer, and Type II Diabetes among others.

Olipass Headlines

No Headlines